Radiodermatitis Market Poised to Reach USD 517.27 Million by 2029, Driven by Rising Cancer Incidence and Advancements in Treatment Modalities
The global radiodermatitis market is projected to grow from USD 442.1 million in 2024 to USD 517.27 million by 2029, registering a compound annual growth rate (CAGR) of 3.99%. This growth is primarily fueled by the increasing prevalence...